Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia
- 1 February 1994
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 73 (5) , 339-345
- https://doi.org/10.1016/0002-9149(94)90005-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemiaThe American Journal of Medicine, 1993
- Niacin revisited: Clinical observations on an important but underutilized drugThe American Journal of Medicine, 1991
- Effects of probucol on plasma lipoprotein subfractions and activities of lipoprotein lipase and hepatic triglyceride lipaseAtherosclerosis, 1991
- Niacin-Induced Hepatitis: A Potential Side Effect With Low-Dose Time-Release NiacinMayo Clinic Proceedings, 1991
- The efficacy and safety of pravastatin, compared to and in combination with bile acid binding resins, in familial hypercholesterolaemiaJournal of Internal Medicine, 1990
- Lens Opacities Classification SystemArchives of Ophthalmology (1950), 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative UltracentrifugeClinical Chemistry, 1972